133 related articles for article (PubMed ID: 6302824)
21. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
22. Correlation between mixed lymphocyte cultures and anti-Epstein Barr virus (EBV) antibodies in Hodgkin's disease and non Hodgkin lymphoma patients.
Sasiain MC; Fejes M; Ares BR; Brezavscek D; Bachmann AE
Biomedicine; 1981 Oct; 35(5):153-6. PubMed ID: 6274439
[TBL] [Abstract][Full Text] [Related]
23. [Recent aspects of Epstein-Barr virus infections].
Hasler F
Schweiz Med Wochenschr; 1984 Apr; 114(15):520-3. PubMed ID: 6328644
[TBL] [Abstract][Full Text] [Related]
24. Lack of relationship between the Epstein-Barr virus and the antiperinuclear factor/'perinuclear antigen' system in rheumatoid arthritis.
Buisson M; Berthelot JM; Le Goff P; Chastel C; Lamour A; Seigneurin JM; Youinou P
J Autoimmun; 1994 Aug; 7(4):485-95. PubMed ID: 7980850
[TBL] [Abstract][Full Text] [Related]
25. [Is there a relationship between Epstein-Barr virus and rheumatoid arthritis (author's transl)].
Lemaire V
Nouv Presse Med; 1982 May; 11(25):1945-7. PubMed ID: 6287408
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to a new antigen induced by Epstein-Barr virus in patients with nasopharyngeal carcinoma, leukemia, malignant lymphoma, and in control groups.
Ida S; Sairenji T; Hinuma Y
Gan; 1972 Feb; 63(1):49-55. PubMed ID: 4339712
[No Abstract] [Full Text] [Related]
27. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
Gunven P
G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
[No Abstract] [Full Text] [Related]
28. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
Yang CS; Hewetson JF
Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
[No Abstract] [Full Text] [Related]
29. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
[TBL] [Abstract][Full Text] [Related]
30. [Anti-RANA antibodies and rheumatoid arthritis].
Kranjc I; Novak D
Reumatizam; 1989; 36(1-6):20-3. PubMed ID: 2491398
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma.
Banatvala JE; Best JM; Waller DK
Lancet; 1972 Jun; 1(7762):1205-8. PubMed ID: 4113190
[No Abstract] [Full Text] [Related]
33. Epstein-Barr virus in human disease.
Langenhuysen MM; The TH
Neth J Med; 1973; 16(2):85-93. PubMed ID: 4350284
[No Abstract] [Full Text] [Related]
34. [Antibodies against capsid (VCA) and nuclear (EBNA) antigens of the Epstein-Barr virus in patients with rheumatoid arthritis].
Dostál C; Vojtĕchovský K; Hána I; Zvárová J
Cas Lek Cesk; 1987 Feb; 126(8):237-40. PubMed ID: 3028635
[No Abstract] [Full Text] [Related]
35. [Clinical study on antibodies against EBV in sera of patients with rheumatoid arthritis].
Zhang X; Li B; Liu Y; Jiang M
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Feb; 21(1):8-12. PubMed ID: 12569633
[TBL] [Abstract][Full Text] [Related]
36. [Immunological study of nasopharyngeal carcinoma].
Tachibana T
Nihon Ishikai Zasshi; 1971 Jun; 65(11):1387-98. PubMed ID: 4327018
[No Abstract] [Full Text] [Related]
37. Autoantibodies in three populations of Burkitt's lymphoma patients.
Vainio E; Lenoir GM; Franklin RM
Clin Exp Immunol; 1983 Nov; 54(2):387-96. PubMed ID: 6317239
[TBL] [Abstract][Full Text] [Related]
38. [Cell membrane receptor of cultured cells derived from nasopharyngeal carcinoma, Burkitt's lymphoma and infectious mononucleosis].
Nishioka K; Tachibana T; Hirayama T; De Thé G; Klein G
Nihon Ishikai Zasshi; 1971 Jun; 65(11):1398-406. PubMed ID: 4326465
[No Abstract] [Full Text] [Related]
39. Specific neutralizing antibodies in Epstein-Barr virus associated diseases.
Rocchi G; Hewetson J; Henle W
Int J Cancer; 1973 May; 11(3):637-47. PubMed ID: 4364719
[No Abstract] [Full Text] [Related]
40. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
